Table. Insulin Fills With and Without Medicare Part D Before and After the Cap on Cost Sharinga.
| Insulin fills, mean/mo | Beginning of 2023 vs end of 2022, mean difference | Regression analysisb | ||||
|---|---|---|---|---|---|---|
| Sep 2022-Dec 2022 | Jan 2023-Apr 2023 | Individual group | Between-group difference | Difference-in-differences estimate for fills/mo (95% CI) | P value | |
| All insulin fills | ||||||
| With Medicare Part D insurance in those aged 65-74 y | 519 588 | 523 564 | 3976 | 18 466 | 21 719 (20 797 to 22 641) | <.001 |
| Without Medicare Part D insurance in those aged 60-64 y | 344 719 | 330 229 | −14 490 | |||
| Insulin fills with cost sharing of ≤$35 | ||||||
| With Medicare Part D insurance in those aged 65-74 y | 340 509 | 366 928 | 26 419 | 48 285 | 49 515 (48 480 to 50 549) | <.001 |
| Without Medicare Part D insurance in those aged 60-64 y | 242 733 | 220 867 | −21 866 | |||
The data are from IQVIA’s National Prescription Audit and measure monthly prescription fills for insulin dispensed at retail and mail-order pharmacies in the US.
The data were adjusted for trends in insulin fills by year and calendar month.